Aegon (AEGN) AI Stock Analysis

Aegon

(BMV:AEGN)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Improving operating performance and cash generationHigher operating earnings, capital generation, and positive free cash flow indicate improved earnings capacity and liquidity. If sustained, this strengthens Aegon’s ability to fund growth, manage insurance obligations, and support capital returns.

Negative Factors

Volatile earnings and cash-flow consistencyThe recovery has not yet demonstrated through-cycle consistency. Prior losses, thin margins, and uneven free cash flow suggest results remain sensitive to insurance assumptions, markets, and working-capital movements, limiting confidence in durable profitability.

Aegon (AEGN) vs. SPDR S&P 500 ETF (SPY)

Market Cap: MXN 12.40B
Dividend Yield: 5.27%
Average Volume (3M): ―
Price to Earnings (P/E): 11.4
Beta (1Y): 0.00
Revenue Growth: 15.46%
EPS Growth: ―
Country: Mexico
Employees: 15,304
Sector: Financial
Sector Strength: 68
Industry: Insurance - Diversified

Aegon Business Overview & Revenue Model

Company Description

Aegon Ltd. functions as a leading financial services provider, offering a comprehensive suite of insurance, retirement planning, and asset management solutions across its operational regions in the Americas, the Netherlands, and the United Kingdom. T...

Aegon Earnings Call Summary

Earnings Call Date:Aug 19, 2026(Q2-2026)|% Change Since:0.00%|Next Earnings Date:Nov 15, 2023

Earnings Call SentimentPositive

The call presented a predominantly positive operational and financial picture: strong commercial momentum (notably a 54% increase in new life sales), improved operating results (+9% to EUR 804m), higher OCG (+27%), solid free cash flow (EUR 392m) and strengthened holding-level liquidity (EUR 1.7bn). Management advanced strategic U.S. relocation steps and increased shareholder returns. Offsetting negatives included elevated new business strain, assumption/model review charges (EUR 231m net of tax), market-driven capital ratio impacts and some regional/product challenges (China repricing, TAM outflows). On balance, the company is executing its strategy while taking measured capital-management actions to address strain and regulatory impacts.

Positive Updates

Increase in Operating Result

Operating result rose to EUR 804 million in H1 2026, a 9% increase year-over-year, driven by broad-based unit improvements and favorable financial markets.

Negative Updates

Increased New Business Strain and OCG Pressure

OCG rose 27% YoY partly reflecting a large increase in new business strain from accelerated sales (new life sales +54%), requiring capital-management actions (e.g., repositioning portfolios) to manage elevated strain.

Company Guidance

The call reiterated confidence in the outlook while updating a number of quantified targets and near‑term actions: H1 operating result was EUR 804m, operating capital generation EUR 416m and free cash flow EUR 392m, with cash capital at holding at EUR 1.7bn (targeting ≈EUR 1.0bn at year‑end 2026); valuation equity per share rose 4% to EUR 9.42 and net result was EUR 608m. Commercial momentum included new life sales +54% and World Financial Group life and annuity sales +5% and +12% respectively; Transamerica operating result was $756m (+14% in local currency). Capital metrics: group solvency ratio 169% (30 Jun 2026), U.S. RBC 420% (‑4pp; operating level ~400%), gross financial leverage EUR 5bn, and financial‑assets capital employed reduced to $2.4bn (close to the ~$2.1–2.2bn target) with floor reserves just under $500m. Management booked roughly 40% (≈EUR 140m) of the expected EUR 350m relocation costs, expects U.S. GAAP dry runs in H2, has increased H2 share buybacks by EUR 150m to EUR 350m (EUR 227m executed in H1, incl. EUR 27m for SBC), declared an interim dividend of EUR 0.21/share (+11% YoY), and confirmed medium‑term ambitions remain unchanged notwithstanding the Aegon UK sale and transfers.

Aegon Peers Comparison

Overall Rating

UnderperformOutperform

Sector (68)

Financial Indicators

MX:AEGN against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
ACGL	83Outperform	$36.29B	8.59	18.35%	―	-5.29%	14.08%
HIG	82Outperform	$35.46B	7.95	24.13%	1.81%	4.08%	34.70%
BRK.B	77Outperform	$1.16T	13.67	11.86%	―	3.93%	36.30%
GNW	71Outperform	$3.32B	16.11	2.42%	―	-0.68%	19.26%
Sector *	68Neutral	$18.00B	11.42	9.92%	3.81%	9.73%	1.22%
AIG	65Neutral	$42.82B	14.86	7.27%	2.32%	-4.19%	1.09%

* Financial Sector Average

Performance Comparison

MX:AEGN and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
MX:AEGN	Aegon Nv	93.68	0.00	0.00%
AIG	American International Group, Inc.	81.90	4.84	6.28%
ACGL	Arch Capital	106.36	20.36	23.67%
GNW	Genworth Financial Inc	8.78	0.33	3.91%
HIG	Hartford Insurance Group Inc	132.59	10.51	8.61%
BRK.B	Berkshire Hathaway B	542.49	66.81	14.05%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Aegon AI Stock Analysis